Maravai Lifesciences Share Price Today
(NASDAQ: MRVI)

Name: Maravai Lifesciences Share Price Today (NASDAQ: MRVI) - Maravai Lifesciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Maravai Lifesciences share price is $2.81 & ₹244.38 as on 6 Mar 2025, 2.30 'hrs' IST

$2.81

▲

-0.03

(-1.06%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Maravai Lifesciences share price in Dollar and Rupees. Guide to invest in Maravai Lifesciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Maravai Lifesciences, along with analyst recommendations, forecasts, and comprehensive financials.

Maravai Lifesciences share price movements

Today's Low: $2.73
Today's High: $2.87
$2.81
3.02%
Downside
Day's Volatility :4.89%
Upside
1.92%
52 Weeks Low: $2.81
52 Weeks High: $11.56
$2.81
0.0%
Downside
52 Weeks Volatility :75.68%
Upside
75.68%

Maravai Lifesciences (MRVI) Returns

Period	Maravai Lifesciences Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-44.2%	2.1%	0.0%
6 Months	-67.13%	-4.1%	0.0%
1 Year	-60.99%	2.2%	0.0%
3 Years	-92.65%	11.8%	-11.6%

Maravai Lifesciences (MRVI) Key Statistics

in dollars & INR

Previous Close	$2.84
Open	$2.81
Today's High	$2.865
Today's Low	$2.725
Market Capitalization	$762.6M
Today's Volume	$744.9K
52 Week High	$11.555
52 Week Low	$2.725
Revenue TTM	$276.9M
EBITDA	$1.0M
Earnings Per Share (EPS)	$-1.66
Profit Margin	-81.13%
Quarterly Earnings Growth YOY	-0.33%
Return On Equity TTM	-42.93%

How to invest in Maravai Lifesciences Stock (MRVI) from India?

It is very easy for Indian residents to invest directly in Maravai Lifesciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Maravai Lifesciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Maravai Lifesciences or MRVI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Maravai Lifesciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Maravai Lifesciences shares which would translate to 0.309 fractional shares of Maravai Lifesciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Maravai Lifesciences, in just a few clicks!

Returns in Maravai Lifesciences (MRVI) for Indian investors in Rupees

The Maravai Lifesciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Maravai Lifesciences investment value today

Current value as on today

₹43,562

Returns

₹56,438

(-56.44%)

Returns from Maravai Lifesciences Stock

₹61,401 (-61.4%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Maravai Lifesciences (MRVI)

-11%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Maravai Lifesciences Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Maravai Lifesciences

GTCR LLC
14.21%
Mackenzie Investments
8.72%
Vanguard Group Inc
8.33%
12 West Capital Management LP
8.17%
BlackRock Inc
6.89%
BRAIDWELL LP
5.89%

Analyst Recommendation on Maravai Lifesciences

Buy

78%Buy

21%Hold

0%Sell

Based on 19 Wall street analysts offering stock ratings for Maravai Lifesciences(by analysts ranked 0 to 5 stars)

Based on 19 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Maravai Lifesciences Stock (MRVI)

What analysts predicted

Upside of 211.24%

Target:

$8.75

Current:

$2.81

Insights on Maravai Lifesciences Stock (Ticker Symbol: MRVI)

Price Movement
In the last 1 month, MRVI stock has moved down by -42.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 73.4M → 65.2M (in $), with an average decrease of 11.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.58M → -99.03M (in $), with an average decrease of 1205.7% per quarter
MRVI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 122.4%
MRVI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 140.5%
Price to Sales
ForMRVI every $1 of sales, investors are willing to pay $1.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

MRVI Maravai Lifesciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$123.8M	-
Net Income	$-17.7M	-
Net Profit Margin	-14.32%	-

	FY19	Y/Y Change
Revenue	$143.1M	↑ 15.59%
Net Income	$-5.2M	↓ 70.67%
Net Profit Margin	-3.63%	↑ 10.69%

	FY20	Y/Y Change
Revenue	$284.1M	↑ 98.48%
Net Income	$76.9M	↓ 1578.33%
Net Profit Margin	27.06%	↑ 30.69%

	FY21	Y/Y Change
Revenue	$799.2M	↑ 181.33%
Net Income	$469.3M	↑ 510.3%
Net Profit Margin	58.71%	↑ 31.65%

	FY22	Y/Y Change
Revenue	$883.0M	↑ 10.48%
Net Income	$490.7M	↑ 4.56%
Net Profit Margin	55.57%	↓ 3.14%

	FY23	Y/Y Change
Revenue	$288.9M	↓ 67.28%
Net Income	$-119.0M	↓ 124.26%
Net Profit Margin	-41.19%	↓ 96.76%

	Q2 FY23	Q/Q Change
Revenue	$68.9M	↓ 12.79%
Net Income	$-6.5M	↑ 385.24%
Net Profit Margin	-9.49%	↓ 7.78%

	Q3 FY23	Q/Q Change
Revenue	$66.9M	↓ 2.97%
Net Income	$-6.5M	↓ 1.21%
Net Profit Margin	-9.66%	↓ 0.17%

	Q4 FY23	Q/Q Change
Revenue	$74.1M	↑ 10.88%
Net Income	$-106.0M	↑ 1539.72%
Net Profit Margin	-142.92%	↓ 133.26%

	Q1 FY24	Q/Q Change
Revenue	$64.2M	↓ 13.44%
Net Income	$-12.1M	↓ 88.6%
Net Profit Margin	-18.82%	↑ 124.1%

	Q2 FY24	Q/Q Change
Revenue	$73.4M	↑ 14.37%
Net Income	$-7.6M	↓ 37.2%
Net Profit Margin	-10.33%	↑ 8.49%

	Q3 FY24	Q/Q Change
Revenue	$65.2M	↓ 11.17%
Net Income	$-99.0M	↑ 1205.71%
Net Profit Margin	-151.9%	↓ 141.57%

	FY18	Y/Y Change
Profit	$63.1M	-

	FY19	Y/Y Change
Profit	$76.3M	↑ 20.97%

	FY20	Y/Y Change
Profit	$204.4M	↑ 167.99%

	FY21	Y/Y Change
Profit	$658.7M	↑ 222.17%

	FY22	Y/Y Change
Profit	$714.0M	↑ 8.41%

	FY23	Y/Y Change
Profit	$140.2M	↓ 80.37%

	Q2 FY23	Q/Q Change
Profit	$25.6M	↓ 43.46%

	Q3 FY23	Q/Q Change
Profit	$30.2M	↑ 17.7%

	Q4 FY23	Q/Q Change
Profit	$38.4M	↑ 27.35%

	Q1 FY24	Q/Q Change
Profit	$19.0M	↓ 50.63%

	Q2 FY24	Q/Q Change
Profit	$35.1M	↑ 85.13%

	Q3 FY24	Q/Q Change
Profit	$28.4M	↓ 19.23%

	FY18	Y/Y Change
Operating Cash Flow	$-186.0K	-
Investing Cash Flow	$-3.5M	-
Financing Cash Flow	$-9.2M	-

	FY19	Y/Y Change
Operating Cash Flow	$24.1M	↓ 13065.05%
Investing Cash Flow	$-17.1M	↑ 396.9%
Financing Cash Flow	$-4.2M	↓ 54.54%

	FY20	Y/Y Change
Operating Cash Flow	$152.2M	↑ 531.09%
Investing Cash Flow	$6.1M	↓ 135.39%
Financing Cash Flow	$53.2M	↓ 1376.99%

	FY21	Y/Y Change
Operating Cash Flow	$368.6M	↑ 142.18%
Investing Cash Flow	$105.7M	↑ 1641.18%
Financing Cash Flow	$-159.0M	↓ 398.9%

	FY22	Y/Y Change
Operating Cash Flow	$536.0M	↑ 45.42%
Investing Cash Flow	$-267.6M	↓ 353.29%
Financing Cash Flow	$-187.5M	↑ 17.89%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$19.2M	↓ 77.44%
Investing Cash Flow	$-24.2M	↓ 65.36%
Financing Cash Flow	$-43.1M	↑ 124.55%

Maravai Lifesciences Technicals Summary

Sell

Neutral

Buy

Maravai Lifesciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Maravai Lifesciences (MRVI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Maravai Lifesciences Holdings Inc	-42.51%	-67.13%	-60.99%	-92.65%	-92.53%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Maravai Lifesciences Holdings Inc	45.97	NA	NA	-0.08	-0.43	-0.02	NA	2.44
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Maravai Lifesciences Holdings Inc	Buy	$762.6M	-92.53%	45.97	-81.13%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Maravai Lifesciences

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Organization	Maravai Lifesciences
Employees	580
CEO	Mr. William E. Martin III
Industry	Commercial Services

Management People of Maravai Lifesciences

Name	Title
Mr. William E. Martin III	CEO & Director
Mr. Kevin M. Herde CPA	Executive VP & CFO
Dr. Peter Michael Leddy Ph.D.	Executive VP & Chief Administrative Officer
Ms. Christine Dolan	Executive Vice President of Biologics Safety Testing
Mr. Robert Andrew Eckert MBA	Chairman of the Board
Ms. Debra Hart	Senior Director of Investor Relations
Mr. Kurt Oreshack J.D.	Executive VP, General Counsel & Secretary
Ms. Rebecca Buzzeo	Executive VP & Chief Commercial Officer
Dr. Kate E. Broderick Ph.D.	Chief Innovation Officer

Important FAQs about investing in MRVI Stock from India :

What is Maravai Lifesciences share price today?

Maravai Lifesciences share price today stands at $2.81, Open: $2.81 ; Previous Close: $2.84 ; High: $2.87 ; Low: $2.73 ; 52 Week High: $11.56 ; 52 Week Low: $2.81.

The stock opens at $2.81, after a previous close of $2.84. The stock reached a daily high of $2.87 and a low of $2.73, with a 52-week high of $11.56 and a 52-week low of $2.81.

Can Indians buy Maravai Lifesciences shares?

Yes, Indians can invest in the Maravai Lifesciences (MRVI) from India.

With INDmoney, you can buy Maravai Lifesciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Maravai Lifesciences at zero transaction cost.

How can I buy Maravai Lifesciences shares from India?

It is very easy to buy Maravai Lifesciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Maravai Lifesciences (MRVI) be purchased?

Yes, you can buy fractional shares of Maravai Lifesciences with INDmoney app.

What are the documents required to start investing in Maravai Lifesciences stocks?

To start investing in Maravai Lifesciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.